Advances in the management of hepatobiliary and pancreatic malignancies: highlights from the ESMO Annual Meeting 2023 by the EORTC GI Tract Cancer Group by C. Fulgenzi, I. Garajová, M. Moehler, M.P. Lutz, E. Smyth, L. Rimassa, C. Neuzillet, A. Lamarca

Get full text

EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol by A. Petrillo, L. Oudijk, R. Sundar, C. Daumer, J. Casas, D. D’Haese, M. Mauer, N. van Grieken, E.C. Smyth, M. Moehler

Get full text

A wind of change in upper gastrointestinal cancers: updates from ESMO 2023 by A. Cammarota, A.R. Siebenhüner, M.A. Maqueda, T. Fleitas-Kanonnikoff, H. van Laarhoven, C. de la Fouchardière, R. Obermannova, M. Moehler, E.C. Smyth

Get full text

Current practices and challenges in implementing precision medicine for upper gastrointestinal cancers in European academic centers: an EORTC survey by M. Alsina, A.E. Huerta, F. Lordick, S. Verschueren, M. Moehler, E. Fontana, E. Smyth, F. Sclafani, A.D. Wagner, L. Rimassa, A. Lamarca, C. Neuzillet, R. Obermannová

Get full text

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial by Martin Kropff, Honorata Giongco Baylon, Jens Hillengass, Tadeusz Robak, Roman Hajek, Peter Liebisch, Stefan Goranov, Cyrille Hulin, Joan Bladé, Tommaso Caravita, Herve Avet-Loiseau, Thomas M. Moehler, Claire Pattou, Lela Lucy, Elisabeth Kueenburg, Axel Glasmacher, Robert Zerbib, Thierry Facon

Get full text